Loading...
Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
PURPOSE: To evaluate frequency of injections, visual and anatomical outcomes of neovascular age-related macular degeneration (nAMD) patients transitioned to intravitreal aflibercept after failure to extend treatment interval beyond 8 weeks with prior intravitreal bevacizumab or ranibizumab. METHODS:...
Na minha lista:
| Udgivet i: | Eye (Lond) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565952/ https://ncbi.nlm.nih.gov/pubmed/26021870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.87 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|